Posts tagged as:


The Federal Trade Commission (“FTC”) has taken action in the recent months to target advertisers in the nutraceutical market for advertising deemed misleading. I couldn’t be more thrilled. This is something that is long overdue and unfortunately, even with the changes that have been made by those who are FTC compliant; the acceptance by most […]


Over the past few months, the FTC has filed a number of complaints against affiliates for failing to clearly and conspicuously disclose financial terms as required by Section 144 of the Truth in Lending Act “TILA” and Section 226.24 (c) of Regulation Z. TILA and Regulation Z require that lending entities disclose finance charges and […]